|
2017 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
CuyĂ s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartĂn, MarĂa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
CuyĂ s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartĂn, MarĂa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
CuyĂ s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartĂn, MarĂa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
2018 June 5 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
CuyĂ s, Elisabet
; Corominas Faja, Bruna
; Muñoz-San MartĂn, MarĂa
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
2012 April |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
2018 June 5 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
2014 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrĂguez Gallego, Esther
; CufĂ González, SĂlvia
; Corominas Faja, Bruna
; CuyĂ s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrĂguez Gallego, Esther
; CufĂ González, SĂlvia
; Corominas Faja, Bruna
; CuyĂ s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrĂguez Gallego, Esther
; CufĂ González, SĂlvia
; Corominas Faja, Bruna
; CuyĂ s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
2018 June 5 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; RodrĂguez Gallego, Esther
; CufĂ González, SĂlvia
; Corominas Faja, Bruna
; CuyĂ s, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
CuyĂ s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrĂguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
CuyĂ s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrĂguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
2018 June 5 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
CuyĂ s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrĂguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
2015 May 20 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
CuyĂ s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrĂguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
2020 February 15 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
CuyĂ s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrĂguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|